These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27637473)

  • 21. Superior performance of co-cultured mesenchymal stem cells and hepatocytes in poly(lactic acid-glycolic acid) scaffolds for the treatment of acute liver failure.
    Liu M; Yang J; Hu W; Zhang S; Wang Y
    Biomed Mater; 2016 Feb; 11(1):015008. PubMed ID: 26836957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraportal mesenchymal stem cell transplantation prevents acute liver failure through promoting cell proliferation and inhibiting apoptosis.
    Sang JF; Shi XL; Han B; Huang T; Huang X; Ren HZ; Ding YT
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):602-611. PubMed ID: 27919849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine kinase 1 dependent protein kinase C-δ activation plays an important role in acute liver failure in mice.
    Lei YC; Yang LL; Li W; Luo P
    World J Gastroenterol; 2015 Dec; 21(48):13438-46. PubMed ID: 26730154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
    Wang J; Wang H; Shi J; Ding Y
    Int J Clin Exp Pathol; 2015; 8(10):12028-40. PubMed ID: 26722388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of IL-1Ra chitosan nanoparticles enhances the therapeutic efficacy of mesenchymal stem cell transplantation in acute liver failure.
    Xiao JQ; Shi XL; Ma HC; Tan JJ; Lin-zhang ; Xu Q; Ding YT
    Arch Med Res; 2013 Jul; 44(5):370-9. PubMed ID: 23916885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmenter of liver regeneration improves therapeutic effect of hepatocyte homotransplantation in acute liver failure rats.
    Wang N; Wang Z; Sun H; Shi X; Zhang Y; Liu Q
    Int Immunopharmacol; 2013 Feb; 15(2):325-32. PubMed ID: 23337881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.
    Yang NB; Ni SL; Li SS; Zhang SN; Hu DP; Lu MQ
    Int J Clin Exp Pathol; 2015; 8(8):9062-71. PubMed ID: 26464648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].
    Wu Y; Liang L; Shi G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1009-12. PubMed ID: 25270198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen Attenuates Lipopolysaccharide/Galactosamine-induced Acute Liver Failure by Antagonizing Hepatic Inflammation and Apoptosis.
    Zhang P; Zhang M; Wan M; Huang X; Jiang Y; Xu S; Luo M
    Immunol Invest; 2017 Apr; 46(3):284-294. PubMed ID: 27967264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key immune-related genes associated with LPS/D-GalN-induced acute liver failure in mice based on transcriptome sequencing.
    Chen L; Yuan L; Yang J; Pan Y; Wang H
    PeerJ; 2023; 11():e15241. PubMed ID: 37168540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells.
    Lei YC; Yang LL; Li W; Luo P; Zheng PF
    World J Gastroenterol; 2015 Dec; 21(46):13055-63. PubMed ID: 26676341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect evaluation of interleukin-1 receptor antagonist nanoparticles for mesenchymal stem cell transplantation.
    Shi XL; Zhu W; Tan JJ; Xiao JQ; Zhang L; Xu Q; Ma ZL; Ding YT
    World J Gastroenterol; 2013 Mar; 19(12):1984-91. PubMed ID: 23569345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined mesenchymal stem cell transplantation and interleukin-1 receptor antagonism after partial hepatectomy.
    Sang JF; Shi XL; Han B; Huang X; Huang T; Ren HZ; Ding YT
    World J Gastroenterol; 2016 Apr; 22(16):4120-35. PubMed ID: 27122663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chymase inhibition attenuates lipopolysaccharide/ d-galactosamine-induced acute liver failure in hamsters.
    Imai Y; Takai S; Jin D; Komeda K; Tashiro K; Li ZL; Otsuki Y; Okamura H; Hayashi M; Uchiyama K
    Pharmacology; 2014; 93(1-2):47-56. PubMed ID: 24457951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow or adipose tissue mesenchymal stem cells: Comparison of the therapeutic potentials in mice model of acute liver failure.
    Zare H; Jamshidi S; Dehghan MM; Saheli M; Piryaei A
    J Cell Biochem; 2018 Jul; 119(7):5834-5842. PubMed ID: 29575235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with β-Adrenoceptor Agonist Isoproterenol Reduces Non-parenchymal Cell Responses in LPS/D-GalN-Induced Liver Injury.
    Wu Y; Ni T; Zhang M; Fu S; Ren D; Feng Y; Liang H; Zhang Z; Zhao Y; He Y; Yang Y; Tian Z; Yan T; Liu J
    Inflammation; 2024 Apr; 47(2):733-752. PubMed ID: 38129360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with D-galactosamine-induced acute liver failure.
    Zhang L; Kang W; Lei Y; Han Q; Zhang G; Lv Y; Li Z; Lou S; Liu Z
    Toxicol Lett; 2011 Jul; 204(1):92-9. PubMed ID: 21550386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.